Literature DB >> 31682655

STATEMENT ON THE RECOMMENDED USE OF HERPES ZOSTER VACCINE: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)*†.

Kevin Laupland.   

Abstract

Year:  2010        PMID： 31682655      PMCID： PMC6802439          DOI： 10.14745/ccdr.v36i00a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


× No keyword cloud information.
  36 in total

1.  Evidence-based recommendations for immunization--methods of the National Advisory Committee on Immunization. An Advisory Committee Statement (ACS).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2009-01

2.  The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.

Authors:  Marc Brisson; James M Pellissier; Stéphanie Camden; Caroline Quach; Philippe De Wals
Journal:  Hum Vaccin       Date:  2010-05-25

3.  Varicella immunity: persistent serologic non-response to immunization.

Authors:  R K Katial; S Ratto-Kim; K V Sitz; R Moriarity; R J Engler
Journal:  Ann Allergy Asthma Immunol       Date:  1999-05       Impact factor: 6.347

Review 4.  Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction.

Authors:  M Takahashi; H Kamiya; Y Asano; K Shiraki; K Baba; T Otsuka; T Hirota; K Yamanishi
Journal:  Arch Virol Suppl       Date:  2001

Review 5.  Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia.

Authors:  Robert H Dworkin; John W Gnann; Anne Louise Oaklander; Srinivasa N Raja; Kenneth E Schmader; Richard J Whitley
Journal:  J Pain       Date:  2008-01       Impact factor: 5.820

6.  Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect.

Authors:  M J Levin; D Barber; E Goldblatt; M Jones; B LaFleur; C Chan; D Stinson; G O Zerbe; A R Hayward
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

7.  Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Rafael Harpaz; Ismael R Ortega-Sanchez; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2008-06-06

8.  Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.

Authors:  M Brisson; N J Gay; W J Edmunds; N J Andrews
Journal:  Vaccine       Date:  2002-06-07       Impact factor: 3.641

9.  Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.

Authors:  M J Levin; M N Oxman; J H Zhang; G R Johnson; H Stanley; A R Hayward; M J Caulfield; M R Irwin; J G Smith; J Clair; I S F Chan; H Williams; R Harbecke; R Marchese; S E Straus; A Gershon; A Weinberg
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

10.  A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.

Authors:  Barbara P Yawn; Patricia Saddier; Peter C Wollan; Jennifer L St Sauver; Marge J Kurland; Lina S Sy
Journal:  Mayo Clin Proc       Date:  2007-11       Impact factor: 7.616
View more
  1 in total

1.  Summary of the NACI Update on Herpes Zoster Vaccines.

Authors:  R Warrington; S Ismail
Journal:  Can Commun Dis Rep       Date:  2018-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.